exhibit 10. 2 immuno - oncology license and collaboration agreement by and between sanofi biotechnology sas and regeneron pharmaceuticals, inc. dated as of july 1, 2015 certain portions of this exhibit have been omitted pursuant to a request for confidentiality. such omitted portions, which are marked with brackets and three asterisks [ * * * ], have been separately filed with the commission. certain portions of this exhibit have been omitted pursuant to a request for confidentiality. such omitted portions, which are marked with brackets and three asterisks [ * * * ], have been separately filed with the commission. table of contents article i definitions article ii collaboration2. 1scope of collaboration2. 2compliance with law2. 3further assurances and transaction approvals2. 4compliance with third party agreements2. 5commercially reasonable efforts ; plans2. 6limitation on exercise of rights outside of collaboration article iii information exchange and updates, management3. 1committees and management3. 2immuno - oncology steering committee3. 3joint development committee3. 4joint commercialization committee3. 5reporting country / regions ; country / region commercialization committees3. 6joint finance committee3. 7joint manufacturing committee3. 8membership3. 9meetings3. 10decision - making ; authority3. 11resolution of committee matters3. 12alliance management3. 13obligations of the parties3. 14exchange of information article iv license grants4. 1regeneron license grants4. 2sanofi license grants4. 3newly created intellectual property4. 4sublicensing4. 5no implied license4. 6retained rights article v development activities5. 1development of io licensed products5. 2post - poc principal party5. 3regn2810 global development plan and regn2810 global development budget5. 4global development plans and global development budgets5. 5additional trials article i definitions article ii collaboration2. 1scope of collaboration2. 2compliance with law2. 3further assurances and transaction approvals2. 4compliance with third party agreements2. 5commercially reasonable efforts ; plans2. 6limitation on exercise of rights outside of collaboration article iii information exchange and